S. Chevret et al., A new prognostic classification for predicting survival in patients with hepatocellular carcinoma, J HEPATOL, 31(1), 1999, pp. 133-141
Background/Aims: In patients with hepatocellular carcinoma, prediction of s
urvival is difficult. The aim of this prospective study was to provide a si
mple classification for predicting survival of patients with hepatocellular
carcinoma, based on a multivariable Cox model,
Methods: Seven hundred and sixty-one patients who presented with hepatocell
ular carcinoma from 24 Western medical centers were enrolled over a 30-mont
h period. Patients were randomly assigned to either a training sample (n=50
6, with 418 deaths) from which a classification system was established, or
a test sample (n=255, with 200 deaths) for validating its prognostic signif
icance.
Results: Five prognostic factors were selected at the 0.0001 level: Karnofs
ky index <80% (relative risk of death=2.2, 95% confidence interval: 1.7-2.7
), serum bilirubin >50 mu mol/l (relative risk = 2.1, 95% confidence interv
al: 1.7-2.6), serum alkaline phosphatase at least twice the upper limit of
normal range (relative risk = 1.6, 95% confidence interval: 1.3-2.0), serum
alpha-fetoprotein >35 mu g/l (relative risk = 1.7, 95% confidence interval
: 1.4-2.1), and ultrasonographic portal obstruction (relative risk = 1.3, 9
5% confidence interval: 1.1-1.7), Three risk groups with different 1-year s
urvival rates (72%, 34%, 7%) were derived, and independently validated in t
he test sample (79%, 31%, 4%),
Conclusion: This classification could be useful in the assessment of progno
sis from homogeneous groups of patients with respect to their expected outc
ome.